Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Bifidobacterium bifidum BGN4 is a probiotic strain that has been used as a major ingredient to produce nutraceutical products and as a dairy starter since 2000. The various bio-functional effects and potential for industrial application of B. bifidum BGN4 has been characterized and proven by in vitro (i.e., phytochemical bio-catalysis, cell adhesion and anti-carcinogenic effects on cell lines, and immunomodulatory effects on immune cells), in vivo (i.e., suppressed allergic responses in mouse model and anti-inflammatory bowel disease), and clinical studies (eczema in infants and adults with irritable bowel syndrome). Recently, the investigation of the genome sequencing was finished and this data potentially clarifies the biochemical characteristics of B. bifidum BGN4 that possibly illustrate its nutraceutical functionality. However, further systematic research should be continued to gain insight for academic and industrial applications so that the use of B. bifidum BGN4 could be expanded to result in greater benefit. This review deals with multiple studies on B. bifidum BGN4 to offer a greater understanding as a probiotic microorganism available in functional food ingredients. In particular, this work considers the potential for commercial application, physiological characterization and exploitation of B. bifidum BGN4 as a whole.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 2×
“, neutrophils, monocytes and ma rophages) in the intestinal mucosa play an es e tial rol in both stimulation of inflammatory re po ses against potential enteric pathogens and tolerance of normal colonic luminal nutrients and microbes as an innate immune system [79].”
BackgroundFiber and prebiotics: Mechanisms and health benefits
Slavin, J. (2013) · Nutrients · doi:10.3390/nu5041417 · Cited by 2,340 · cited 1×
“, bacteriocins) [50–52]; (ii) assimilation of dietary fibers [53]; (iii) regulation of fat storage [54,55]; (iv) modulation of mucosal immunity [56]; and (v) regulation of gut flora via competitive exclusion of pathogenic bacteria resulting in decreased pathogen colonization [57–59].”
BackgroundFunctional food. Product development, marketing and consumer acceptance—a review
Siró, I., Kápolna, E., Kápolna, B., & Lugasi, A. (2008) · Appetite · doi:10.1016/j.appet.2008.05.060 · Cited by 1,758 · cited 2×
“, biomedical and pharmaceutical markets) exploitation beyond food or nutraceuticals, and consumers’ paradigm shift seems be necessary for successful commercial applications [1,9].”
BackgroundHost interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens
Lebeer, S., Vanderleyden, J., & De Keersmaecker, S. C. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2297 · Cited by 1,062 · cited 1×
“Among the five key functional effects of probiotics, attachment of probiotic bacteria onto the mucosal surface of the gastrointestinal tract is regarded as essential for the competitive exclusion of pathogens and must occur before effective regulation of immune activities, resulting in protective function against inte…”
BackgroundDiversity of Bifidobacteria within the Infant Gut Microbiota
Turroni, F., Peano, C., Pass, D. A., Foroni, E., Severgnini, M., Claesson, M. J., Kerr, C., Hourihane, J., Murray, D., Fuligni, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036957 · Cited by 647
Gill, H. S., Rutherfurd, K. J., Cross, M. L., & Gopal, P. K. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.6.833 · Cited by 485 · cited 1×
“Multiple reports have shown a significantly promoted phagocytic capacity of phagocytes by probiotic supplementation as an immunomodulator [83].”
BackgroundKomatsuzaki, N., Shima, J., Kawamoto, S., Momose, H., & Kimura, T. (2005) · Food Microbiology · doi:10.1016/j.fm.2005.01.002 · Cited by 391 · cited 1×
“[127], maintaining low pH (about 5) is necessary for effective GABA production.”
BackgroundTurroni, F., Bottacini, F., Foroni, E., Mulder, I., Kim, J.-H., Zomer, A., Sánchez, B., Bidossi, A., Ferrarini, A., Giubellini, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011100107 · Cited by 364
Treatment of Fibromyalgia Syndrome With Antidepressants: A Meta-analysis
Häuser, W., Bernardy, K., Üçeyler, N., & Sommer, C. (2009) · JAMA · doi:10.1001/jama.2008.944 · Cited by 338
Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro
Choi, S. S., Kim, Y., Han, K. S., You, S., Oh, S., & Kim, S. H. (2006) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2006.01913.x · Cited by 292
Research works printed but not linked: 125
- Syngai, 2015, Probiotics—The versatile vunctional food ingredients, J. Food Sci. Technol., 53, 921, 10.1007/s13197-015-2011-0 · DOI
- Mauriello, 2016, Probiotication of foods: A focus on microencapsulation tool, Trends Food Sci. Technol., 48, 27, 10.1016/j.tifs.2015.11.009 · DOI · Paper page
- Yildiz, F. (2010). Development and Manufacture of Yogurt and Other Functional Dairy Products, CRC Press/Taylor & Francis. · DOI
- Preedy, V. (2012). Handbook of Diet, Nutrition and The Skin, Wageningen Academic Publisher. · doi:10.3920/978-90-8686-729-5
- Sarkar, 2016, Probiotics: A way of value addition in functional food, Int. J. Food Sci. Nutr. Diet., 5, 290
- Tajabadi, 2015, Optimization Of γ-Aminobutyric acid production by Lactobacillus plantarum Taj-Apis362 from honeybees, Molecules, 20, 6654, 10.3390/molecules20046654 · DOI
- Ku, 2016, Finding and producing probiotic glycosylases for the biocatalysis of ginsenosides: A mini review, Molecules, 21, 645, 10.3390/molecules21050645 · DOI
- Soto, 2014, Lactobacilli and bifidobacteria in human bBreast milk: Influence of antibiotherapy and other host and clinical factors, J. Pediatr. Gastroenterol. Nutr., 59, 78, 10.1097/MPG.0000000000000347 · DOI · Paper page
- Farver, 2015, The influence of early infant-feeding practices on the intestinal microbiome and body composition in infants, Nutr. Metab. Insights, 8, 1
- Grguric, 1996, Microflora in the digestive tract of infants, Mljekarstvo, 46, 291
- Saavedra, 2007, Use of probiotics in pediatrics: Rationale, mechanisms of action, and practical aspects, Nutr. Clin. Pract., 22, 351, 10.1177/0115426507022003351 · DOI · Paper page
- Lewis, Z.T., Totten, S.M., Smilowitz, J.T., Popovic, M., Parker, E., Lemay, D.G., van Tassell, M.L., Miller, M.J., Jin, Y.S., and German, J.B. (2015). Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome, 3. · DOI · Paper page
- Harmsen, 2000, Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods, J. Pediatr. Gastroenterol. Nutr., 30, 61
- Aggett, 2003, Nondigestible carbohydrates in the diets of infants and young children: A commentary by the ESPGHAN Committee on Nutrition, J. Pediatr. Gastroenterol. Nutr., 36, 329
- Turroni, F., Duranti, S., Bottacini, F., Guglielmetti, S., van Sinderen, D., and Ventura, M. (2014). Bifidobacterium bifidum as an example of a specialized human gut commensal. Front. Microbiol., 5. · DOI · Paper page
- Wang, 2013, Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora, World J. Microbiol. Biotechnol., 30, 847, 10.1007/s11274-013-1490-2 · DOI
- Culpepper, 2016, Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: A secondary analysis of a randomised trial, Benef. Microbes, 7, 327, 10.3920/BM2015.0156 · DOI
- Choi, 1996, Growth and β-Glucosidase activity of bifidobacterium, J. Microbiol. Biotechnol., 6, 255
- Kim, 2003, Characterization of adhesion of Bifidobacterium sp. BGN4 to human enterocyte-like Caco-2 cells, J. Microbiol. Biotechnol., 13, 276
- Ku, 2009, Enhancement of anti-tumorigenic polysaccharide production, adhesion, and branch formation of Bifidobacterium bifidum BGN4 by phytic acid, Food Sci. Biotechnol., 18, 749
- Lee, 2002, Cytoskeleton reorganization and cytokine production of macrophages by bifidobacterial cells and cell-free extracts, J. Microbiol. Biotechnol., 12, 398
- Kim, 2006, Modulatory activity of Bifidobacterium sp. BGN4 cell fractions on immune cells, J. Microbiol. Biotechnol., 16, 584
- Lee, 2006, Regulatory effect on specific ige response of Bifidobacterium bifidum (BGN4 Strain) in murine model of peanut allergy, J. Allergy Clin. Immunol., 117, S204, 10.1016/j.jaci.2005.12.806 · doi:10.1016/j.jaci.2005.12.806
- Kim, 2007, Oral feeding of Bifidobacterium bifidum (BGN4) Prevents CD4 + CD45RB high T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation, Clin. Immunol., 123, 30, 10.1016/j.clim.2006.11.005 · DOI
- Kim, 2010, Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial, Pediatr. Allergy Immunol., 21, 386, 10.1111/j.1399-3038.2009.00958.x · DOI · Paper page
- Kim, 2012, Probiotic modulation of dendritic cells co-cultured with intestinal epithelial cells, World J. Gastroenterol., 18, 1308, 10.3748/wjg.v18.i12.1308 · DOI
- You, 2004, Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4, FEMS Microbiol. Lett., 240, 131, 10.1016/j.femsle.2004.09.020 · DOI
- Youn, 2012, Identification of the β-glucosidase gene from Bifidobacterium animalis Subsp. Lactis and its expression in B. bifidum BGN4, J. Microbiol. Biotechnol., 22, 1714, 10.4014/jmb.1208.08028 · doi:10.4014/jmb.1208.08028
- Kim, 2012, Cloning and expression of β-Glucosidases from Bifidobacterium lactis AD011, Food Sci. Biotechnol., 21, 731, 10.1007/s10068-012-0095-0 · DOI
- Wang, 2012, Novel Bifidobacterium promoters selected through microarray analysis lead to constitutive high-level gene expression, J. Microbiol., 50, 638, 10.1007/s12275-012-1591-x · DOI
- Kim, 2014, Production of γ-aminobutyric acid during fermentation of Gastrodia Elata Bl. By co-culture of Lactobacillus brevis GABA 100 with Bifidobacterium bifidum BGN4, Food Sci. Biotechnol., 23, 459, 10.1007/s10068-014-0063-y · DOI
- You, 2015, High expression of β-glucosidase in Bifidobacterium bifidum BGN4 and application in conversion of isoflavone glucosides during fermentation of soy milk, J. Microbiol. Biotechnol., 25, 469, 10.4014/jmb.1408.08013 · DOI
- Kim, 2008, Development of S-adenosyl-l-methionine (SAM)-reinforced probiotic yogurt using Bifidobacterium bifidum BGN4, Food Sci. Biotechnol., 17, 1025
- Kim, 2008, Evaluation of S-adenosyl-l-methionine production by Bifidobacterium bifidum BGN4, Food Sci. Biotechnol., 17, 184
- Yu, 2012, Complete genome sequence of the probiotic bacterium Bifidobacterium bifidum strain BGN4, J. Bacteriol., 194, 4757, 10.1128/JB.00988-12 · DOI
- Ribet, 2015, How bacterial pathogens colonize their hosts and invade deeper tissues, Microbes Infect., 17, 173, 10.1016/j.micinf.2015.01.004 · DOI · Paper page
- Brandt, 2015, Acetylated rhamnogalacturonans from immature fruits of Abelmoschus esculentus inhibit the adhesion of Helicobacter pylori to human gastric cells by interaction with outer membrane proteins, Molecules, 20, 16770, 10.3390/molecules200916770 · doi:10.3390/molecules200916770
- Kim, 2015, Fructooligosaccharides decreased the ability of probiotic Escherichia coli Nissle 1917 to adhere to co-cultures of human intestinal cell lines, J. Korean Soc. Appl. Biol. Chem., 58, 45, 10.1007/s13765-015-0002-5 · DOI
- Serafini, 2013, Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010, Anaerobe, 21, 9, 10.1016/j.anaerobe.2013.03.003 · DOI
- Underwood, 2012, Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: Antimicrobial peptide and protein responses, Pediatr. Res., 71, 546, 10.1038/pr.2012.11 · DOI
- Martinez, 2013, Bacteriocin production by Bifidobacterium spp: A review, Biotechnol. Adv., 31, 482, 10.1016/j.biotechadv.2013.01.010 · DOI · Paper page
- Mandal, 2014, Recombinant probiotics with antimicrobial peptides: A dual strategy to improve immune response in immunocompromised patients, Drug Discov. Today, 19, 1045, 10.1016/j.drudis.2014.05.019 · DOI
- Aronsson, L., Huang, Y., Parini, P., Korach-André, M., Håkansson, J., Gustafsson, J., Pettersson, S., Arulampalam, V., and Rafter, J. (2010). Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS ONE, 5. · DOI · Paper page
- DiBaise, 2012, Impact of the gut microbiota on the development of obesity: Current concepts, Am. J. Gastroenterol. Suppl., 1, 22, 10.1038/ajgsup.2012.5 · DOI · Paper page
- Hardy, 2013, Probiotics, prebiotics and immunomodulation of gut mucosal defences: Homeostasis and immunopathology, Nutrients, 5, 1869, 10.3390/nu5061869 · DOI · Paper page
- Yu, 2010, Ability of Lactobacillus to inhibit enteric pathogenic bacteria adhesion on Caco-2 cells, World J. Microbiol. Biotechnol., 27, 881, 10.1007/s11274-010-0530-4 · DOI
- Kim, 2014, Evaluation of two Bacillus subtilis strains isolated from Korean fermented food as probiotics against loperamide-induced constipation in mice, J. Korean Soc. Appl. Biol. Chem., 57, 797, 10.1007/s13765-014-4106-0 · DOI
- Lim, 2014, Anti-helicobacter pylori activity of antimicrobial substances produced by lactic acid bacteria isolated from Baikkimchi, J. Korean Soc. Appl. Biol. Chem., 57, 621, 10.1007/s13765-014-4198-6 · DOI
- Miller, 2011, Lactobacillus adhesion to mucus, Nutrients, 3, 613, 10.3390/nu3050613 · DOI · Paper page
- Duary, 2011, Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells, Indian J. Med. Res., 134, 664, 10.4103/0971-5916.90992 · DOI · Paper page
- Paduch, 2014, The effect of cell surface components on adhesion ability of Lactobacillus rhamnosus, Antonie van Leeuwenhoek, 106, 751, 10.1007/s10482-014-0245-x · DOI · Paper page
- Krasowska, 2014, How microorganisms use hydrophobicity and what does this mean for human needs?, Front. Cell. Infect. Microbiol., 4, 112, 10.3389/fcimb.2014.00112 · DOI · Paper page
- Pelletier, 1997, Cell surface characteristics of Lactobacillus casei subsp. casei, Lactobacillus paracasei subsp. paracasei, and Lactobacillus rhamnosus strains, Appl. Environ. Microbiol., 63, 1725, 10.1128/aem.63.5.1725-1731.1997 · DOI · Paper page
- Abdulla, 2014, Adhesion, Autoaggregation and hydrophobicity of six Lactobacillus strains, Br. Microbiol. Res. J., 4, 381, 10.9734/BMRJ/2014/6462 · DOI · Paper page
- Boris, 1998, Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens, Infect. Immun., 66, 1985, 10.1128/IAI.66.5.1985-1989.1998 · DOI · Paper page
- Shakirova, 2010, Influence of growth conditions on hydrophobicity of Lactobacillus acidophilus and Bifidobacterium lactis cells and characteristics by FT-IR spectra, J. Spectrosc., 24, 251, 10.1155/2010/659167 · doi:10.1155/2010/659167
- Minnaard, 1998, Surface properties of bifidobacterial strains of human origin, J. Microbiol. Biotechnol., 64, 21
- Pan, 2006, The correlation between surface hydrophobicity and adherence of Bifidobacterium strains from centenarians’ faeces, Anaerobe, 12, 148, 10.1016/j.anaerobe.2006.03.001 · DOI
- Schillinger, 2005, In vitro adherence and other properties of lactobacilliused in probiotic yoghurt-like products, Int. Dairy J., 15, 1289, 10.1016/j.idairyj.2004.12.008 · DOI · Paper page
- Alzate, 2008, Comparison of biotransformation of inorganic selenium by Lactobacillus and Saccharomyces in lactic fermentation process of yogurt and kefir, J. Agric. Food Chem., 56, 8728, 10.1021/jf8013519 · DOI · Paper page
- Botes, 2008, Adhesion of the probiotic strains enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to Caco-2 cells under conditions simulating the intestinal tract, and in the presence of antibiotics and anti-inflammatory medicaments, Arch. Microbiol., 190, 573, 10.1007/s00203-008-0408-0 · DOI
- Andersson, 1987, Surface properties of lactobacilli isolated from the small intestine of pigs, J. Appl. Bacteriol., 62, 513, 10.1111/j.1365-2672.1987.tb02683.x · DOI · Paper page
- Candela, 2008, Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production, Int. J. Food Microbiol., 125, 286, 10.1016/j.ijfoodmicro.2008.04.012 · DOI · Paper page
- Crociani, 1995, Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with in vivo study, Lett. Appl. Microbiol., 21, 146, 10.1111/j.1472-765X.1995.tb01027.x · DOI · Paper page
- Borchers, 2009, Probiotics and immunity, J. Gastroenterol., 44, 26, 10.1007/s00535-008-2296-0 · DOI · Paper page
- Galdeano, 2007, Proposed model: Mechanisms of immunomodulation induced by probiotic bacteria, Clin. Vaccine Immunol., 14, 485, 10.1128/CVI.00406-06 · DOI · Paper page
- Kim, 2015, Different shapes of Al2O3 particles induce differential cytotoxicity via a mechanism involving lysosomal destabilization and reactive oxygen species generation, J. Korean Soc. Appl. Biol. Chem., 58, 433, 10.1007/s13765-015-0038-6 · DOI
- Li, 2016, Chemical structure and immunomodulating activities of an α-glucan purified from Lobelia chinensis lour, Molecules, 21, 779, 10.3390/molecules21060779 · DOI
- Cui, 2016, Regulation of Candida albicans interaction with macrophages through the activation of HOG pathway by genistein, Molecules, 21, 162, 10.3390/molecules21020162 · DOI
- Fong, F.L., Shah, N.P., Kirjavainen, P., and El-Nezami, H. (2015). Mechanism of action of probiotic bacteria on intestinal and systemic immunities and antigen-presenting cells. Int. Rev. Immunol., 1–11. · DOI · Paper page
- Pourhoseingholi, 2012, Increased burden of colorectal cancer in Asia, World J. Gastrointest. Oncol., 4, 68, 10.4251/wjgo.v4.i4.68 · DOI
- Kumar, 2012, Probiotic metabolites as epigenetic targets in the prevention of colon cancer, Nutr. Rev., 71, 23, 10.1111/j.1753-4887.2012.00542.x · DOI · Paper page
- Uccello, M., Malaguarnera, G., Basile, F., D’agata, V., Malaguarnera, M., Bertino, G., Vacante, M., Drago, F., and Biondi, A. (2012). Potential role of probiotics on colorectal cancer prevention. BMC Surg., 12. · DOI · Paper page
- Raman, M., Ambalam, P., and Doble, M. (2016). Probiotics and Bioactive Carbohydrates in Colon Cancer Management, Springer (India) Pvt. Ltd. · DOI
- Mohammadi, 2014, Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain, Iran J. Basic Med. Sci., 17, 815
- Nagaoka, 1994, Anti-ulcer effects of lactic acid bacteria and their cell wall polysaccharides, Biol. Pharm. Bull., 17, 1012, 10.1248/bpb.17.1012 · DOI · Paper page
- Li, 2005, Caco-2 cell permeability assays to measure drug absorption, Expert Opin. Drug. Metab. Toxicol., 1, 175, 10.1517/17425255.1.2.175 · DOI · Paper page
- Corpet, 2002, Most effective colon cancer chemopreventive agents in rats: A systematic review of aberrant crypt foci and tumor data, ranked by potency, Nutr. Cancer, 43, 1, 10.1207/S15327914NC431_1 · DOI · Paper page
- Kim, 2008, Aberrant crypt focus size predicts distal polyp histopathology, Cancer Epidemiol. Biomark. Prev., 17, 1155, 10.1158/1055-9965.EPI-07-2731 · doi:10.1158/1055-9965.epi-07-2731
- Foerst, P., and Santivarangkna, C. (2015). Advances in Probiotic Technology, CRC Press/Taylor & Francis.
- Daniel, 2013, Probiotics from research to market: The possibilities, risks and challenges, Curr. Opin. Microbiol., 16, 284, 10.1016/j.mib.2013.06.008 · DOI · Paper page
- Nedović, V., Raspor, P., Lević, J., Tumbas Šaponjac, V., and Barbosa-Cánovas, G. (2016). Emerging and Traditional Technologies for Safe, Healthy and Quality Food, Springer International Publishing. · DOI
- Park, 2012, Whole cell biotransformation of major ginsenosides using leuconostocs and lactobacilli, Food Sci. Biotechnol., 21, 839, 10.1007/s10068-012-0108-z · doi:10.1007/s10068-012-0108-z
- You, 2010, Transformation of Rutin to antiproliferative quercetin-3-glucoside by Aspergillus niger, J. Agric. Food Chem., 58, 10886, 10.1021/jf102871g · DOI
- Ku, 2011, Optimization of β-glucuronidase activity from Lactobacillus delbrueckii Rh2 and its use for biotransformation of baicalin and wogonoside, J. Korean Soc. Appl. Biol. Chem., 54, 275, 10.3839/jksabc.2011.043 · DOI
- Ku, 2015, Effects of ascorbic acid on α-l-arabinofuranosidase and α-l-arabinopyranosidase activities from Bifidobacterium longum RD47 and its application to whole cell bioconversion of ginsenoside, J. Korean Soc. Appl. Biol. Chem., 58, 857, 10.1007/s13765-015-0113-z · DOI
- Ku, 2016, Whole-cell biocatalysis for producing ginsenoside Rd from Rb1 using Lactobacillus rhamnosus GG, J. Microbiol. Biotechnol., 26, 1206, 10.4014/jmb.1601.01002 · doi:10.4014/jmb.1601.01002
- Gao, 2013, Biotransformation, a promising technology for anti-cancer drug development, Asian Pac. J. Cancer Prev., 14, 5599, 10.7314/APJCP.2013.14.10.5599 · doi:10.7314/apjcp.2013.14.10.5599
- Sasidharan, 2011, Extraction, isolation and characterization of bioactive compounds from plants’ extracts, Afr. J. Tradit. Complement Altern. Med., 8, 1
- Han, 1982, Degradation of ginseng saponins under mild acidic conditions, Planta Med., 44, 146, 10.1055/s-2007-971425 · DOI
- Chen, 1987, Alkaline cleavage of ginsenosides, Chem. Pharm. Bull., 35, 1653, 10.1248/cpb.35.1653 · doi:10.1248/cpb.35.1653
- Nag, S.A., Qin, J.J., Wang, W., Wang, M.H., Wang, H., and Zhang, R. (2012). Ginsenosides as anticancer agents: In vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front. Pharmacol., 3. · DOI · Paper page
- Taku, 2011, Soy isoflavones for osteoporosis: An evidence-based approach, Maturitas, 70, 333, 10.1016/j.maturitas.2011.09.001 · DOI
- Orgaard, 2008, The effects of soy isoflavones on obesity, Exp. Biol. Med., 233, 1066, 10.3181/0712-MR-347 · DOI · Paper page
- Lu, 2008, Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats, Nutr. Res., 28, 464, 10.1016/j.nutres.2008.03.009 · DOI
- Rafii, 2015, The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol, Metabolites, 5, 56, 10.3390/metabo5010056 · DOI · Paper page
- Kennedy, 1995, The evidence for soybean products as cancer preventive agents, J. Nutr., 125, 733, 10.1093/jn/125.3_Suppl.733S · DOI · Paper page
- Bawa, 2010, The significance of soy protein and soy bioactive compounds in the prophylaxis and treatment of osteoporosis, J. Osteoporos., 2010, 1, 10.4061/2010/891058 · DOI
- Kuo, 2012, A process for high-efficiency isoflavone deglycosylation using Bacillus subtilis natto NTU-18, Appl. Microbiol. Biotechnol., 94, 1181, 10.1007/s00253-012-3884-8 · DOI
- Hayakawa, 2004, Effect of a γ-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats, Br. J. Nutr., 92, 411, 10.1079/BJN20041221 · DOI · Paper page
- Adeghate, 2002, GABA in the endocrine pancreas: Cellular localization and function in normal and diabetic rats, Tissue Cell, 34, 1, 10.1054/tice.2002.0217 · DOI · Paper page
- Mazzacane, 2009, Synthesis of γ-aminobutyric acid (GABA) by Lactobacillus plantarum DSM19463: Functional grape must beverage and dermatological applications, Appl. Microbiol. Biotechnol., 86, 731
- Li, H., Qiu, T., Huang, G., and Cao, Y. (2010). Production of γ-aminobutyric acid by Lactobacillus brevis NCL912 using fed-batch fermentation. Microb. Cell Fact., 9. · DOI · Paper page
- Huh, 1995, Effect of the ether fraction of Gastrodia elata methanol extract on the pentylenetetrazole-induced seizures, J. Appl. Pharmacol., 3, 199
- Lee, 2012, Effects of acidic polysaccharides from Gastrodia rhizome on systolic blood pressure and serum lipid concentrations in spontaneously hypertensive rats fed a high-fat diet, Int. J. Mol. Sci., 13, 698, 10.3390/ijms13010698 · DOI
- Matos, 1987, S-adenosylmethionine: Studies on chemical and enzymatic synthesis, Biotechnol. Appl. Biochem., 9, 39, 10.1111/j.1470-8744.1987.tb00461.x · doi:10.1111/j.1470-8744.1987.tb00461.x
- Papakostas, 2003, S-adenosyl-methionine in depression: A comprehensive review of the literature, Curr. Psychiatry Rep., 5, 460, 10.1007/s11920-003-0085-2 · DOI
- Lieber, 2002, S-adenosyl-l-methionine: Its role in the treatment of liver disorders, Am. J. Clin. Nutr., 76, 1183, 10.1093/ajcn/76.5.1183S · DOI
- Bernardy, 2009, Treatment of fibromyalgia syndrome with antidepressants, J. Gen. Intern. Med., 301, 198
- Armando, 2013, Statistical optimization of culture conditions for biomass production of probiotic gut-borne Saccharomyces cerevisiae strain able to reduce fumonisin B1, J. Appl. Microbiol., 114, 1338, 10.1111/jam.12144 · DOI
- Rani, 2011, Optimization of culture conditions for bacterial cellulose production from Gluconacetobacter hansenii UAC09, Ann. Microbiol., 61, 781, 10.1007/s13213-011-0196-7 · doi:10.1007/s13213-011-0196-7
- Kwon, 2006, High concentration cultivation of Bifidobacterium bifidum in a submerged membrane bioreactor, Biotechnol. Prog., 22, 1591, 10.1021/bp060236s · doi:10.1021/bp060236s
- Dias, 1968, Calcium nutrition of Sphaerotilus growing in a continuous-flow apparatus, Appl. Microbiol., 16, 1364, 10.1128/am.16.9.1364-1369.1968 · doi:10.1128/am.16.9.1364-1369.1968
- Snellen, 1970, Morphogenesis and fine structure of Leucothrix mucor and effects of calcium deficiency, J. Bacteriol., 101, 240, 10.1128/jb.101.1.240-249.1970 · doi:10.1128/jb.101.1.240-249.1970
- Wright, 1981, Calcium-induced alteration of cellular morphology affecting the resistance of Lactobacillus acidophilus to freezing, Appl. Environ. Microbiol., 41, 807, 10.1128/aem.41.3.807-815.1981 · doi:10.1128/aem.41.3.807-815.1981
- Arena, 2015, Probiotic administration modifies the milk fatty acid profile, intestinal morphology, and intestinal fatty acid profile of goats, J. Dairy Sci., 98, 47, 10.3168/jds.2013-7805 · DOI
- Kojima, 1970, Necessity of calcium ion for cell division in Lactobacillus bifidus, J. Bacteriol., 104, 1010, 10.1128/jb.104.2.1010-1013.1970 · doi:10.1128/jb.104.2.1010-1013.1970
- Duranti, 2015, Insights from genomes of representatives of the human gut commensal Bifidobacterium bifidum, Environ. Microbiol., 17, 2515, 10.1111/1462-2920.12743 · DOI · Paper page
- Lugil, 2014, Investigation of the evolutionary development of the genus Bifidobacterium by comparative genomics, Appl. Environ. Microbiol., 80, 6383, 10.1128/AEM.02004-14 · DOI · Paper page
- Milani, 2016, Genomics of the genus Bifidobacterium reveals species-specific adaptation to the glycan-rich gut environment, Appl. Environ. Microbiol., 82, 980, 10.1128/AEM.03500-15 · DOI · Paper page
- Ventura, 2007, Genomics as a means to understand bacterial phylogeny and ecological adaptation: The case of bifidobacteria, Antonie van Leeuwenhoek, 91, 351, 10.1007/s10482-006-9122-6 · DOI
- Ventura, 2007, From bacterial genome to functionality; case bifidobacteria, Int. J. Food Mirobiol., 120, 2, 10.1016/j.ijfoodmicro.2007.06.011 · DOI
- Turroni, 2016, Deciphering bifidobacterial-mediaated metabolic interactions and their impact of gut microbiota by a multi-omics approach, ISME J., 10, 1656, 10.1038/ismej.2015.236 · DOI · Paper page
- Russell, 2011, Metabolic activities and probiotic potential of bifidobacteria, Int. J. Food Microbiol., 149, 88, 10.1016/j.ijfoodmicro.2011.06.003 · DOI · Paper page
- Milani, 2014, Genomic encyclopedia of type strains of the genus Bifidobacterium, Appl. Environ. Microbiol., 80, 6290, 10.1128/AEM.02308-14 · DOI · Paper page
Cited by
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties
Maftei, N.-M., Raileanu, C. R., Balta, A. A., Ambrose, L., Boev, M., Marin, D. B., & Lisa, E. L. (2024) · Microorganisms · doi:10.3390/microorganisms12020234 · Cited by 381
Probiotics in the dairy industry—Advances and opportunities
Gao, J., Li, X., Zhang, G., Sadiq, F. A., Simal‐Gandara, J., Xiao, J., & Sang, Y. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12755 · Cited by 195
Qureshi, N., Gu, Q., & Li, P. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14627 · Cited by 64
“Adhesion of probiotic to the epithelial surface is critical for competitive exclusion of pathogens and immunomodulation mechanism (Ku et al. 2016).”
BackgroundSelleri, E., Longhi, G., Tarracchini, C., Carolis, E. D., Petraro, S., Mancabelli, L., Milani, C., Turroni, F., Ventura, M., & Lugli, G. A. (2026) · Microbiome Research Reports · doi:10.20517/mrr.2026.19
Metadata
- Authors
- Ku, S., Park, M., Ji, G., & You, H.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2016-09-14
- Volume
- 17
- Issue
- 9
- Pages
- 1544
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2519778240
- Cited by
- 106
- References
- 17
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism. https://app.cochat.ai/papers/10.3390/ijms17091544
- The paper
- Ku, S., Park, M., Ji, G., & You, H. (2016). Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms17091544
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.